Skip to main content
Clinical Trials/JPRN-jRCT1030230648
JPRN-jRCT1030230648
Active, not recruiting
未知

A non-interventional, prospective, observational study of a motion capture device (AKIRA) in patients with amyotrophic lateral sclerosis (ALS)

Hirai Manabu0 sites35 target enrollmentFebruary 22, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hirai Manabu
Enrollment
35
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Hirai Manabu

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients will be diagnosed with Definite ALS, Probable ALS, or Probable laboratory\-supported ALS according to the El Escorial revised criteria for the diagnosis of ALS
  • 2\. Patients will be \>\= 20 years of age at the time the ICF is signed
  • 3\. Patients who can walk independently at a specified distance for video shooting
  • 4\. Patients who regularly visit the Yoshino Clinic about once a month
  • 5\. Patients who provided a signed and dated informed consent form (ICF) to participate in the study

Exclusion Criteria

  • 1\. Patients who have the presence of any clinically significant disease
  • 2\. Patients who are not eligible to participate in the study, as judged by the Investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials